Results 201 to 210 of about 222,938 (359)

Delayed presentation of a retained colonic segment in a child with intestinal failure on teduglutide

open access: yesJPGN Reports, EarlyView.
Abstract Teduglutide is a glucagon‐like peptide 2 (GLP‐2) analogue that was approved by the United States Food and Drug Administration for the treatment of pediatric (>1 year) intestinal failure due to short bowel syndrome in 2019. GLP‐2 analogues promote rapid intestinal adaptation, increasing the absorptive capacity of residual intestine after ...
Rachel C. Bordelon   +6 more
wiley   +1 more source

Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. [PDF]

open access: yesJ Clin Med
Zeina AR   +8 more
europepmc   +1 more source

Glucagon-stimulating activity of 20 amino acids in dogs [PDF]

open access: bronze, 1972
Dalva Marreiro Rocha   +2 more
openalex   +1 more source

Persimmon carotenoid extract rich in β‐cryptoxanthin improves glucose homeostasis and reduces liver damage in high‐fat‐diet‐induced type 2 diabetic and metabolic dysfunction‐associated steatotic liver disease mice

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Background Persimmon (Diospyros kaki Thunb.) byproducts are a remarkable source of bioactive compounds, particularly carotenoids. Several studies suggest that carotenoids have beneficial effects in prevention of a large number of diseases. This study aims to highlight the effects of a persimmon carotenoid extract (PSCE) rich in β‐cryptoxanthin
Bryan Moreno‐Chamba   +10 more
wiley   +1 more source

α cells use both PC1/3 and PC2 to process proglucagon peptides and control insulin secretion. [PDF]

open access: yesSci Adv
Cui C   +13 more
europepmc   +1 more source

Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background There is a growing body of literature suggesting that GLP‐1 receptor agonists (GLP‐1RAs) may be associated with hair loss; however, primary literature is sparse. Additionally, it is not well‐established which types of hair loss may be associated with GLP‐1RA use. Objectives This study aims to assess associations between GLP‐1RAs and
Lauren M. Ching   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy